StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3082% below fair value
$0.98+0.02 (+2.50%)

Close on Nov 18, 2026Market cap $11.49MP/E –Yield –

Bionano Genomics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Bionano Genomics's operating income for the twelve months ending Jun 30, 2026 was -$32.19M. For fiscal 2025 it was -$33.34M. The highest annual figure on record is -$20.42M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$33.34M–
FY2024Dec 31, 2024-$103.98M–
FY2023Dec 31, 2023-$215.25M–
FY2022Dec 31, 2022-$131.70M–
FY2021Dec 31, 2021-$77.10M–
FY2020Dec 31, 2020-$38.55M–
FY2019Dec 31, 2019-$25.87M–
FY2018Dec 31, 2018-$20.42M–
FY2017Dec 31, 2017-$23.22M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.22M–
Q1 FY2026Mar 31, 2026-$7.90M–
Q4 FY2025Dec 31, 2025-$8.54M–
Q3 FY2025Sep 30, 2025-$8.54M–
Q2 FY2025Jun 30, 2025-$7.80M–
Q1 FY2025Mar 31, 2025-$8.47M–
Q4 FY2024Dec 31, 2024-$11.94M–
Q3 FY2024Sep 30, 2024-$43.90M–
Q2 FY2024Jun 30, 2024-$17.02M–
Q1 FY2024Mar 31, 2024-$31.12M–
Q4 FY2023Dec 31, 2023-$24.95M–
Q3 FY2023Sep 30, 2023-$113.21M–
Q2 FY2023Jun 30, 2023-$39.24M–
Q1 FY2023Mar 31, 2023-$37.84M–
Q4 FY2022Dec 31, 2022-$37.53M–
Q3 FY2022Sep 30, 2022-$32.15M–
Q2 FY2022Jun 30, 2022-$32.08M–
Q1 FY2022Mar 31, 2022-$29.94M–
Q4 FY2021Dec 31, 2021-$28.78M–
Q3 FY2021Sep 30, 2021-$20.68M–
Q2 FY2021Jun 30, 2021-$16.48M–
Q1 FY2021Mar 31, 2021-$11.16M–
Q4 FY2020Dec 31, 2020-$11.13M–
Q3 FY2020Sep 30, 2020-$10.23M–
Q2 FY2020Jun 30, 2020-$7.44M–
Q1 FY2020Mar 31, 2020-$9.76M–
Q4 FY2019Dec 31, 2019-$7.16M–
Q3 FY2019Sep 30, 2019-$5.69M–
Q2 FY2019Jun 30, 2019-$6.84M–
Q1 FY2019Mar 31, 2019-$6.19M–
Q4 FY2018Dec 31, 2018-$6.10M–
Q3 FY2018Sep 30, 2018-$5.97M–
Q2 FY2018Jun 30, 2018-$4.01M–
Q1 FY2018Mar 31, 2018-$4.34M–
Q4 FY2017Dec 31, 2017-$5.24M–
Q3 FY2017Sep 30, 2017-$5.03M–

More Bionano Genomics figures

See a number that looks wrong?